Search
Results for “Medication overuse”
Articles
-
Medication Overuse/Adaptation Headache
Comprehensive guide to medication overuse headache (MOH/MAH): understand causes, symptoms, and evidence-based treatments. Learn about CGRP therapies, withdrawal protocols, prevention strategies, and breakthrough research showing detox...
-
Endocannabinoid System Genetics Breakthrough in Medication Overuse Headache
Breakthrough genetics study reveals FAAH gene changes in medication overuse headache. Endocannabinoid DNA differences could transform diagnosis and treatment.
-
Medication Overuse Headache aka Medication Adaptation Headache aka Rebound Headache: A Comprehensive Guide
A clinical guide to medication overuse headache, also called medication adaptation or rebound headache: causes, diagnosis, withdrawal, and prevention.
-
Medication Overuse Headache (MOH) AKA Rebound Headache Treatment Has Changed- MOTS Trial
The MOTS trial changed how medication overuse (rebound) headache is treated: starting a preventive without forced withdrawal worked as well.
-
New Research Shows Migraine Patients with Medication Overuse/Adaptation Headache May Have Leaky Gut
A Journal of Headache and Pain study links chronic migraine with medication overuse headache to markers of leaky gut. Key findings and limitations.
-
How Migraine Medications Are Tested
Ever wondered how migraine medications are proven safe and effective? This is the article for you.
-
Choosing Migraine Medications Based on Administration Routes
Complete guide to migraine drug delivery methods: oral tablets, nasal sprays, injections & topical treatments. Compare onset times, effectiveness & side effects for optimal migraine relief....
-
Study Finds Acid Reflux Medications Linked to Higher Risk of Migraine and Severe Headache
A recent study indicates that acid reflux medications, particularly proton pump inhibitors (PPIs), may be associated with a higher risk of migraine and severe headache. Learn...
-
Botox for Chronic Migraine: What 479 Real-World Patients Show
A 479-patient real-world study of onabotulinumtoxinA for chronic migraine found a mean reduction of 5.9 monthly headache days, with 27.3% reaching the 50% response threshold and...
-
Chronic Daily Headache
Chronic daily headache is an umbrella term used to describe a range of primary and secondary headache disorders characterized by duration and/or frequency depending on the...
-
Acute migraine pharmaceutical treatment cheat sheet
A quick reference for acute migraine medications, including acetaminophen, NSAIDs, triptans, and antiemetics, with typical doses and maximums.
-
Acute Treament of Tension-Type Headache (TTH)
Acute treatment of tension-type headache: which pain relievers and combinations work best, dosing, and how to avoid medication overuse.
-
New Daily Persistent Headache (NDPH) with Q&A
What is New daily persistent headache (NDPH)?
-
Refractory Migraine Vs. Resistant Migraine Definitions
There are no accepted, universal diagnostic criteria for refractory migraine or resistant migraine in the International Classification of Headache Disorders, 3rd edition (ICHD-3).
-
When should I start migraine prevention therapy?
Reasons why you shoudl start migraine preventive therapy.
-
Cannabis for Migraine: What Randomized Trials Show
A new systematic review graded every randomized trial of cannabinoids for migraine and headache. Vaporized THC plus CBD beat placebo for acute attacks with moderate certainty,...
-
Dr. Jessica Ailani, MD on the Topic of Chronic Migraine (Migraine World Summit- Day 1)
Summary & Key Questions for Dr. Jessica Ailani on the Topic of Chronic Migraine. Migraine World Summit- Day 1
-
How Much Is Too Much Excedrin Migraine? (MWS Day 2)
How Much Is Too Much Excedrin Migraine?
-
The New Migraine Prevention Guideline: What the AAN and AHS Recommend
The American Academy of Neurology and the American Headache Society have published a joint practice guideline on migraine prevention in adults: 17 recommendations and 52 statements....
-
Effectiveness and Tolerability of Atogepant (Qulipta) in the Prevention of Migraine
STAR study shows atogepant (Qulipta) effectively reduces migraine days by 56.6% in real-world clinical practice, even for patients with previous treatment failures. Learn about this breakthrough.
-
Migraine Pharmaceutical Treatment Pearls
Comprehensive expert guide to migraine treatments: evidence-based recommendations for acute medications (NSAIDs, triptans, gepants), preventive therapies, and special considerations for pregnancy, cardiovascular disease, and other medical...
-
Atogepant for Migraine Prevention: What the Data Shows
A new meta-analysis of 6 randomized trials and 3,453 people shows how much atogepant actually reduces monthly migraine days, which dose works best, and what side...
Pages
-
Migraine Resource Hub
The Cerebral Torque Migraine Resource Hub: evidence-based guides on migraine science, subtypes, acute and preventive treatment, and new research.
-
Migraine Science Archive 2026
Older entries from Today in Migraine Science: plain-language summaries of migraine studies, guidelines and news, each linked to its source.
